JAK2 and myeloproliferative neoplasm: As demonstrated herein, JAK2 and PIM inhibitors strongly synergize to inhibit the growth and induce apoptosis in MPN cell lines SET2 and UKE1, as well as in JAK2 inhibitor-resistant clones.